Healthcare
Harmony Biosciences Holdings, Inc.
HRMY$41.25+4.75%
Price is delayed.
Add to Watchlist
About Harmony Biosciences Holdings, Inc.
Harmony Biosciences is a pharmaceutical company that develops and sells medicines for rare neurological diseases. The company's main product is WAKIX, a pill that treats excessive daytime sleepiness in people with narcolepsy. They are testing other medicines in clinical trials for conditions like Prader-Willi Syndrome, narcolepsy variants, epilepsy, and Fragile X Syndrome, which are genetic or neurological disorders that affect relatively few patients.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore